Edwards Lifesciences Cash and Equivalents Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 114.67  1.59  1.41%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Cash and Equivalents of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Total Assets representing the amount of currency on hand as well as demand deposits with banks or financial institutions.
View

1.13 B

            10 Years Trend  
Increasing
Slightly volatile
 Cash and Equivalents 
      Timeline 

Edwards Lifesciences Cash and Equivalents Over Time

2015-12-31  718,400,000 
2016-12-31  930,100,000 
2017-12-31  1,130,000,000 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  456,100,000
Geometric Mean  337,218,146
Coefficient Of Variation  73.33
Mean Deviation  267,983,333
Median  396,100,000
Standard Deviation  334,480,213
Range  1,082,300,000
R Value  0.92
R Squared  0.84
Significance  0.0000282
Slope  84,996,503

Currently Trending

AJRD   
 NYQ 
Purchased over 90 shares of
few hours ago ago
Traded for 34.4
I   
 NYQ 
Purchased over 90 shares of
few hours ago ago
Traded for 6.4
CBAY   
 NCM 
Purchased over 90 shares of
few hours ago ago
Traded for 8.14